BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11243142)

  • 1. [Four novel point mutations of factor IX gene detected by denaturing gradient gel electrophoresis].
    Wang Y; Li Z; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):125-8. PubMed ID: 11243142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
    Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
    Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutations in four hemophilia B patients from China.
    Wang NS; Chen SH; Thompson AR
    Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six novel and three recurrent mutations in nine Austrian patients with hemophilia B.
    Walter J; Pabinger-Fasching I; Watzke HH
    Thromb Haemost; 1994 Jul; 72(1):74-7. PubMed ID: 7974379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroduplex analysis in hemophilia B: detection of two novel factor IX gene mutations.
    Driscoll MC; Chu A; Hilgartner MW
    Am J Hematol; 1996 Apr; 51(4):324-7. PubMed ID: 8602635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection by denaturing gradient gel electrophoresis of an Arg1689Cys mutation in a Chinese patient with mild hemophilia A.
    Ruan C; Gu J; Lavergne JM; Meyer D
    Chin Med J (Engl); 1997 Feb; 110(2):96-9. PubMed ID: 9594277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A directed search for mutations in hemophilia A using restriction enzyme analysis and denaturing gradient gel electrophoresis. A study of seven exons in the factor VIII gene of 170 cases.
    Lavergne JM; Bahnak BR; Vidaud M; Laurian Y; Meyer D
    Nouv Rev Fr Hematol (1978); 1992; 34(1):85-91. PubMed ID: 1523102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
    Tartary M; Vidaud D; Piao Y; Costa JM; Bahnak BR; Fressinaud E; Congard B; Laurian Y; Meyer D; Lavergne JM
    Br J Haematol; 1993 Aug; 84(4):662-9. PubMed ID: 8217825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel missense mutation in the B domain of factor VIII causes severe hemophilia A].
    Liu J; Zhang Y; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):458-60. PubMed ID: 11189482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of gene mutation and genetic analysis of a patient with type 3 von Willebrand disease].
    Li Z; Wang Y; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):122-4. PubMed ID: 11243141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
    Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genetic defects of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1991 Oct; 66(4):459-63. PubMed ID: 1796396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophilia B carrier determination based on family-specific mutation detection by DNA single-strand conformation analysis.
    Poon MC; Anand S; Fraser BM; Hoar DI; Sinclair GD
    J Lab Clin Med; 1993 Jul; 122(1):55-63. PubMed ID: 8320491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.